Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in …

X Hu, W Qin, S Li, M He, Y Wang, S Guan… - Cancer Management …, 2018 - Taylor & Francis
Objective Multiple factors are involved in oxaliplatin-resistant process in colorectal cancer
(CRC) patients including decreased drug accumulation and enhanced capacity to repair …
被引用次数：19 相关文章

Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in …

X Hu, W Qin, S Li, M He, Y Wang… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Objective Multiple factors are involved in oxaliplatin-resistant process in colorectal cancer
(CRC) patients including decreased drug accumulation and enhanced capacity to repair …
[PDF] semanticscholar.org

[PDF][PDF] Polymorphisms in Dna repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in …

W Qin, Y Wang, W Yao, M Wei - Cancer Management …, 2019 - pdfs.semanticscholar.org
Objective: Multiple factors are involved in oxaliplatin-resistant process in colorectal cancer
(CRC) patients including decreased drug accumulation and enhanced capacity to repair …

Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in …

X Hu, W Qin, S Li, M He, Y Wang, S Guan… - Cancer Management …, 2019 - go.gale.com
Objective: Multiple factors are involved in oxaliplatin-resistant process in colorectal cancer
(CRC) patients including decreased drug accumulation and enhanced capacity to repair …

Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in …

X Hu, W Qin, S Li, M He, Y Wang… - Cancer …, 2019 - search.proquest.com
Objective: Multiple factors are involved in oxaliplatin-resistant process in colorectal cancer
(CRC) patients including decreased drug accumulation and enhanced capacity to repair …

Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in …

X Hu, W Qin, S Li, M He, Y Wang, S Guan… - Cancer Management …, 2018 - dovepress.com
Objective: Multiple factors are involved in oxaliplatin-resistant process in colorectal cancer
(CRC) patients including decreased drug accumulation and enhanced capacity to repair …
[HTML] nih.gov

[HTML][HTML] Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in …

X Hu, W Qin, S Li, M He, Y Wang, S Guan… - Cancer Management …, 2019 - ncbi.nlm.nih.gov
Objective Multiple factors are involved in oxaliplatin-resistant process in colorectal cancer
(CRC) patients including decreased drug accumulation and enhanced capacity to repair …

Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in …

X Hu, W Qin, S Li, M He, Y Wang, S Guan… - Cancer Management …, 2018 - europepmc.org
Objective Multiple factors are involved in oxaliplatin-resistant process in colorectal cancer
(CRC) patients including decreased drug accumulation and enhanced capacity to repair …

Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in …

X Hu, W Qin, S Li, M He, Y Wang, S Guan… - Cancer Management …, 2018 - europepmc.org
Objective Multiple factors are involved in oxaliplatin-resistant process in colorectal cancer
(CRC) patients including decreased drug accumulation and enhanced capacity to repair …